|
1
|
Wen PY and Kesari S: Malignant gliomas in
adults. N Engl J Med. 359:492–507. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Doucette T, Rao G, Yang Y, Gumin J,
Shinojima N, Bekele BN, Qiao W, Zhang W and Lang FF: Mesenchymal
stem cells display tumor-specific tropism in an RCAS/Ntv-a glioma
model. Neoplasia. 13:716–725. 2011.PubMed/NCBI
|
|
3
|
Lee DH, Ahn Y, Kim SU, Wang KC, Cho BK,
Phi JH, Park IH, Black PM, Carroll RS, Lee J and Kim SK: Targeting
rat brainstem glioma using human neural stem cells and human
mesenchymal stem cells. Clin Cancer Res. 15:4925–4934. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Pittenger MF, Mackay AM, Beck SC, Jaiswal
RK, Douglas R, Mosca JD, Moorman MA, Simonetti DW, Craig S and
Marshak DR: Multilineage potential of adult human mesenchymal stem
cells. Science. 284:143–147. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Chamberlain G, Fox J, Ashton B and
Middleton J: Concise review: mesenchymal stem cells: their
phenotype, differentiation capacity, immunological features, and
potential for homing. Stem Cells. 25:2739–2749. 2007. View Article : Google Scholar
|
|
6
|
Keunen O, Johansson M, Oudin A, Sanzey M,
Rahim SA, Fack F, Thorsen F, Taxt T, Bartos M, Jirik R, et al:
Anti-VEGF treatment reduces blood supply and increases tumor cell
invasion in glioblastoma. Proc Natl Acad Sci USA. 108:3749–3754.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Knizetova P, Ehrmann J, Hlobilkova A,
Vancova I, Kalita O, Kolar Z and Bartek J: Autocrine regulation of
glioblastoma cell cycle progression, viability and radioresistance
through the VEGF-VEGFR2 (KDR) interplay. Cell Cycle. 7:2553–2561.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Rahmah NN, Sakai K, Sano K and Hongo K:
Expression of RECK in endothelial cells of glioma: comparison with
CD34 and VEGF expressions. J Neurooncol. 107:559–564. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Herzog B, Pellet-Many C, Britton G,
Hartzoulakis B and Zachary IC: VEGF binding to NRP1 is essential
for VEGF stimulation of endothelial cell migration, complex
formation between NRP1 and VEGFR2, and signaling via FAK Tyr407
phosphorylation. Mol Biol Cell. 22:2766–2776. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Schmidt NO, Koeder D, Messing M, Mueller
FJ, Aboody KS, Kim SU, Black PM, Carroll RS, Westphal M and Lamszus
K: Vascular endothelial growth factor-stimulated cerebral
micro-vascular endothelial cells mediate the recruitment of neural
stem cells to the neurovascular niche. Brain Res. 1268:24–37. 2009.
View Article : Google Scholar
|
|
11
|
Yilmaz G and Granger DN: Leukocyte
recruitment and ischemic brain injury. Neuromolecular Med.
12:193–204. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Hyun YM, Chung HL, McGrath JL, Waugh RE
and Kim M: Activated integrin VLA-4 localizes to the lamellipodia
and mediates T cell migration on VCAM-1. J Immunol. 183:359–369.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Hu Y, Cheng P, Xue YX and Liu YH: Glioma
cells promote the expression of vascular cell adhesion molecule-1
on bone marrow-derived mesenchymal stem cells: a possible mechanism
for their tropism toward gliomas. J Mol Neurosci. 48:127–135. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Liu J, Wei Y, Chen Y, Xu X and Zhang H:
Differentiation of neural stem cells influences their chemotactic
responses to vascular endothelial growth factor. J Neurosci Res.
89:1173–1184. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Bekhite MM, Finkensieper A, Binas S,
Müller J, Wetzker R, Figulla HR, Sauer H and Wartenberg M:
VEGF-mediated PI3K class IA and PKC signaling in cardiomyogenesis
and vasculo-genesis of mouse embryonic stem cells. J Cell Sci.
124:1819–1830. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Mias C, Lairez O, Trouche E, Roncalli J,
Calise D, Seguelas MH, Ordener C, Piercecchi-Marti MD, Auge N,
Salvayre AN, et al: Mesenchymal stem cells promote matrix
metalloproteinase secretion by cardiac fibroblasts and reduce
cardiac ventricular fibrosis after myocardial infarction. Stem
Cells. 27:2734–2743. 2009. View
Article : Google Scholar
|
|
17
|
Xu F, Shi J, Yu B, Ni W, Wu X and Gu Z:
Chemokines mediate mesenchymal stem cell migration toward gliomas
in vitro. Oncol Rep. 23:1561–1567. 2010.PubMed/NCBI
|
|
18
|
Jiang B, Xu S, Hou X, Pimentel DR and
Cohen RA: Angiotensin II differentially regulates
interleukin-1-beta-inducible NO synthase (iNOS) and vascular cell
adhesion molecule-1 (VCAM-1) expression: role of p38 MAPK. J Biol
Chem. 279:20363–20368. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Nakamizo A, Marini F, Amano T, Khan A,
Studeny M, Gumin J, Chen J, Hentschel S, Vecil G, Dembinski J, et
al: Human bone marrow-derived mesenchymal stem cells in the
treatment of gliomas. Cancer Res. 65:3307–3318. 2005.PubMed/NCBI
|
|
20
|
Hlobilkova A, Ehrmann J, Knizetova P,
Krejci V, Kalita O and Kolar Z: Analysis of VEGF, Flt-1, Flk-1,
nestin and MMP-9 in relation to astrocytoma pathogenesis and
progression. Neoplasma. 56:284–290. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Korkolopoulou P, Patsouris E,
Konstantinidou AE, Pavlopoulos PM, Kavantzas N, Boviatsis E,
Thymara I, Perdiki M, Thomas-Tsagli E, Angelidakis D, et al:
Hypoxia-inducible factor 1alpha/vascular endothelial growth factor
axis in astrocytomas. Associations with microvessel morphometry,
proliferation and prognosis. Neuropathol Appl Neurobiol.
30:267–278. 2004. View Article : Google Scholar
|
|
22
|
Boveri M, Berezowski V, Price A, Slupek S,
Lenfant AM, Benaud C, Hartung T, Cecchelli R, Prieto P and Dehouck
MP: Induction of blood-brain barrier properties in cultured brain
capillary endothelial cells: comparison between primary glial cells
and C6 cell line. Glia. 51:187–198. 2005. View Article : Google Scholar
|
|
23
|
Miletic H, Niclou SP, Johansson M and
Bjerkvig R: Anti-VEGF therapies for malignant glioma: treatment
effects and escape mechanisms. Expert Opin Ther Targets.
13:455–468. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Segers VF, Van Riet I, Andries LJ, Lemmens
K, Demolder MJ, De Becker AJ, Kockx MM and De Keulenaer GW:
Mesenchymal stem cell adhesion to cardiac microvascular
endothelium: activators and mechanisms. Am J Physiol Heart Circ
Physiol. 290:H1370–H1377. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Rosenman SJ, Shrikant P, Dubb L,
Benveniste EN and Ransohoff RM: Cytokine-induced expression of
vascular cell adhesion molecule-1 (VCAM-1) by astrocytes and
astrocytoma cell lines. J Immunol. 154:1888–1899. 1995.PubMed/NCBI
|
|
26
|
Klemke M, Weschenfelder T, Konstandin MH
and Samstag Y: High affinity interaction of integrin alpha4beta1
(VLA-4) and vascular cell adhesion molecule 1 (VCAM-1) enhances
migration of human melanoma cells across activated endothelial cell
layers. J Cell Physiol. 212:368–374. 2007. View Article : Google Scholar
|
|
27
|
Wewer C, Seibt A, Wolburg H, Greune L,
Schmidt MA, Berger J, Galla HJ, Quitsch U, Schwerk C, Schroten H
and Tenenbaum T: Transcellular migration of neutrophil granulocytes
through the blood-cerebrospinal fluid barrier after infection with
Streptococcus suis. J Neuroinflammation. 8:512011.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Bacic M, Edwards NA and Merrill MJ:
Differential expression of vascular endothelial growth factor
(vascular permeability factor) forms in rat tissues. Growth
Factors. 12:11–15. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wang F, Yamauchi M, Muramatsu M, Osawa T,
Tsuchida R and Shibuya M: RACK1 regulates VEGF/Flt1-mediated cell
migration via activation of a PI3K/Akt pathway. J Biol Chem.
286:9097–9106. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Graupera M, Guillermet-Guibert J, Foukas
LC, Phng LK, Cain RJ, Salpekar A, Pearce W, Meek S, Millan J,
Cutillas PR, Smith AJ, Ridley AJ, Ruhrberg C, Gerhardt H and
Vanhaesebroeck B: Angiogenesis selectively requires the p110alpha
isoform of PI3K to control endothelial cell migration. Nature.
453:662–666. 2008. View Article : Google Scholar : PubMed/NCBI
|
